Adverse events40

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

1 to 20 of 40

Type	Event	Organ system	Group	Affected	At risk	Events
other	Injection site pain	General disorders	Degarelix 240 mg/80 mg	60	181	93
other	Injection site pain	General disorders	Goserelin (3.6 mg) + Bicalutamide (50 mg)	1	64	1
other	Injection site erythema	General disorders	Degarelix 240 mg/80 mg	45	181	73
other	Injection site erythema	General disorders	Goserelin (3.6 mg) + Bicalutamide (50 mg)	0	64	0
other	Asthenia	General disorders	Degarelix 240 mg/80 mg	13	181	15
other	Asthenia	General disorders	Goserelin (3.6 mg) + Bicalutamide (50 mg)	6	64	6
other	Injection site pruritus	General disorders	Degarelix 240 mg/80 mg	13	181	19
other	Injection site pruritus	General disorders	Goserelin (3.6 mg) + Bicalutamide (50 mg)	0	64	0
other	Fatigue	General disorders	Degarelix 240 mg/80 mg	11	181	13
other	Fatigue	General disorders	Goserelin (3.6 mg) + Bicalutamide (50 mg)	6	64	6
other	Injection site swelling	General disorders	Degarelix 240 mg/80 mg	11	181	17
other	Injection site swelling	General disorders	Goserelin (3.6 mg) + Bicalutamide (50 mg)	0	64	0
other	Libido decreased	Psychiatric disorders	Degarelix 240 mg/80 mg	12	181	12
other	Libido decreased	Psychiatric disorders	Goserelin (3.6 mg) + Bicalutamide (50 mg)	4	64	4
other	Pollakiuria	Renal and urinary disorders	Degarelix 240 mg/80 mg	11	181	13
other	Pollakiuria	Renal and urinary disorders	Goserelin (3.6 mg) + Bicalutamide (50 mg)	4	64	4
other	Erectile dysfunction	Reproductive system and breast disorders	Degarelix 240 mg/80 mg	14	181	15
other	Erectile dysfunction	Reproductive system and breast disorders	Goserelin (3.6 mg) + Bicalutamide (50 mg)	7	64	7
other	Hot flush	Vascular disorders	Degarelix 240 mg/80 mg	108	181	132
other	Hot flush	Vascular disorders	Goserelin (3.6 mg) + Bicalutamide (50 mg)	40	64	46

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT00833248/events

API reference For AI assistants

Adverse events40

Sources 3

Read this list from software.